🔎 Trials Near Me

Почетна › Рак крви › Тексас

Kliničke studije za Рак крви u državi Тексас

49 studija za Рак крви traži učesnike na lokacijama u državi Тексас.

Gradovi u državi Тексас

Zvanični tekst studije (na engleskom)

CD70.CAR for AML and Other CD70+ Leukemias

  • Texas Children's Hospital, Houston
  • The Methodist Hospital, Houston
Тражи се учесникФаза 1
До 75 година · Оба пола · Ажурирано 13. 11. 2026. · NCT06345027

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

  • Texas Oncology - Central/South Texas ( Site 8001), Austin
  • Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
  • University of Texas MD Anderson Cancer Center ( Site 0007), Houston
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT03486873

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • Texas Oncology-Austin Midtown, Austin
  • Texas Oncology-Presbyterian Cancer Center, Dallas
  • University of Texas, Houston
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст од 18 до 39 · Оба пола · Ажурирано 10. 11. 2026. · NCT04551378

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • Audie L Murphy VA Hospital, San Antonio
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT04242095

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  • MD Anderson Cancer Center - University of Texas, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07572006

Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

  • MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07809906

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 3
Узраст од 18 до 71 · Оба пола · Ажурирано 30. 10. 2026. · NCT07504458

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Texas Children's Hospital, Houston
Тражи се учесникОпсервациона студија
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT04728893

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • Mays Cancer Center at UT Health San Antonio, San Antonio
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT05745285

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • The University of TX MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07424833

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07648264

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Md Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07195916

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT04888338

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • Cook Children's Medical Center, Fort Worth
  • и још 2
Тражи се учесникФаза 3
Узраст од 2 до 18 · Оба пола · Ажурирано 6. 10. 2026. · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03328078

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

  • M D Anderson Cancer Center, Houston
Тражи се учесникРана фаза 1
Узраст од 12 до 80 · Оба пола · Ажурирано 23. 9. 2026. · NCT04744116

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

  • UT MD Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 9. 2026. · NCT07743476

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • The University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2Здраве особе су добродошле
Сви узрасти · Оба пола · Ажурирано 14. 9. 2026. · NCT04984551

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

  • M D Anderson Cancer Center, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT02464696

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

  • M D Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Сви узрасти · Оба пола · Ажурирано 4. 9. 2026. · NCT03425526

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Baylor Scott & White Health, Dallas
  • MD Anderson, Houston
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT04588922

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 21. 8. 2026. · NCT01772771

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
  • MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

  • M D Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT05110742

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

  • M D Anderson Cancer Center, Houston
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06184321

Expressive Writing for the Management of Stress in Cancer Survivors

  • M D Anderson Cancer Center, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT04776941

The Impact of COVID-19 on Pulmonary Procedures

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Сви узрасти · Оба пола · Ажурирано 10. 8. 2026. · NCT05022446

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 10. 8. 2026. · NCT05108519

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, Irving
  • UT San Antonio Mays Cancer, San Antonio
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06823167

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

  • University of Texas MD Anderson MD Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT06665100

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

  • M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 12 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT04712539

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Medical City Dallas, Dallas
  • Children's Medical Center Dallas, Dallas
  • Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
  • и још 5
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Improving Comprehensive Care of Cancer Patients

  • Baylor College of Medicine, Houston
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 30. 6. 2026. · NCT05323409

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 6. 2026. · NCT02074839

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

  • M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 6. 2026. · NCT00991094

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.